Published in Oncologist on June 29, 2017
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Lessons from hereditary colorectal cancer. Cell (1996) 25.73
The heat-shock response. Annu Rev Biochem (1986) 20.16
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol (2012) 5.06
71,000 HUMAN APPENDIX SPECIMENS. A FINAL REPORT, SUMMARIZING FORTY YEARS' STUDY. Am J Proctol (1963) 4.34
Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol (1995) 4.33
Peritonectomy procedures. Ann Surg (1995) 4.24
Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998. Cancer (2002) 3.89
Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies. Dis Colon Rectum (1998) 3.81
Mucosal hyperplasia, mucinous cystadenoma, and mucinous cystadenocarcinoma of the appendix. A re-evaluation of appendiceal "mucocele". Cancer (1973) 3.57
Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg (1995) 3.41
New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol (2006) 3.36
Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol (1999) 3.21
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res (1996) 3.00
Disconnect between incidence of nonperforated and perforated appendicitis: implications for pathophysiology and management. Ann Surg (2007) 2.98
Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol (2006) 2.82
Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol (2003) 2.74
Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst (1995) 2.62
The natural history of surgically treated primary adenocarcinoma of the appendix. Ann Surg (1994) 2.59
Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg (1994) 2.50
Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res (1980) 2.48
Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women. Am J Pathol (1999) 2.34
Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg (2004) 2.33
Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol (2007) 2.17
Primary appendiceal malignancies: rare but important. Surgery (1992) 2.15
IX. Primary Carcinoma of the Vermiform Appendix, with a Report of Three Cases. Ann Surg (1903) 2.09
Clinical presentation of the Pseudomyxoma peritonei syndrome. Br J Surg (2000) 2.08
Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol (2006) 2.06
The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology (2000) 2.04
Goblet cell carcinoid of the appendix. World J Surg Oncol (2005) 1.87
Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei. A clinicopathological analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol (1991) 1.86
Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol (2010) 1.59
Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol (2007) 1.56
Appendiceal mucinous neoplasms: controversial issues. Arch Pathol Lab Med (2010) 1.55
Epithelial noncarcinoid tumors and tumor-like lesions of the appendix. A clinicopathologic study of 184 patients with a multivariate analysis of prognostic factors. Cancer (1995) 1.53
Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations. Mod Pathol (2002) 1.50
Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. Int J Gynecol Pathol (2002) 1.40
Prognostic Molecular Subtypes of Low-Grade Cancer of the Appendix. J Am Coll Surg (2015) 1.39
Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experience. Cancer (2010) 1.37
Importance of histologic subtype in the staging of appendiceal tumors. Ann Surg Oncol (2012) 1.31
Appendiceal adenocarcinoma: long-term outcomes after surgical therapy. Dis Colon Rectum (2004) 1.27
Microsatellite instability: the mutator that mutates the other mutator. Nat Med (1996) 1.26
Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence. Am J Surg Pathol (2009) 1.26
Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix. Ann Oncol (2011) 1.18
Primary appendiceal adenocarcinoma. Am J Clin Oncol (1999) 1.13
A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei. Br J Cancer (2008) 1.13
Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer (1996) 1.12
Biological and clinical aspects of hyperthermia in cancer therapy. Am J Clin Oncol (1988) 1.09
Improving the AJCC/TNM staging for adenocarcinomas of the appendix: the prognostic impact of histological grade. Ann Surg (2013) 1.05
Hyperthermia in cancer therapy: the biological basis and unresolved questions. Cancer Res (1985) 1.02
FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma. Oncologist (2014) 1.00
Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin. J Surg Oncol (2010) 0.98
A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process. Am J Surg Pathol (2016) 0.94
Pseudomyxoma peritonei and selected other aspects of the spread of appendiceal neoplasms. Semin Diagn Pathol (2004) 0.93
Prognostic significance of localized extra-appendiceal mucin deposition in appendiceal mucinous neoplasms. Am J Surg Pathol (2009) 0.92
VEGF expression predicts survival in patients with peritoneal surface metastases from mucinous adenocarcinoma of the appendix and colon. Ann Surg Oncol (2007) 0.92
Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas. Oncologist (2013) 0.89
Clinicopathological analysis of primary epithelial appendiceal neoplasms. Med Oncol (2009) 0.87
Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival. Gastroenterol Res Pract (2012) 0.85
Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved. Dis Colon Rectum (2013) 0.84
[Appendiceal neoplasm resulting from a malignant transformation of a villous adenoma]. Chirurg (1980) 0.81
Hyperthermic Intraperitoneal Chemotherapy Following Cytoreductive Surgery Improves Outcome in Patients With Primary Appendiceal Mucinous Adenocarcinoma: A Pooled Analysis From Three Tertiary Care Centers. Oncologist (2015) 0.81
The incidence of mucinous appendiceal malignancies: a population-based study. Int J Colorectal Dis (2013) 0.80
Acute intestinal obstruction: an unusual complication of mucocele of appendix. Eur Rev Med Pharmacol Sci (2011) 0.80
The Fifth International Workshop on Peritoneal Surface Malignancy (Milan, Italy, December 4-6, 2006): methodology of disease-specific consensus. J Surg Oncol (2008) 0.79
Incidence and Survival of Appendiceal Mucinous Neoplasms: A SEER Analysis. Am J Clin Oncol (2015) 0.76